Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Liabilities and Shareholders Equity (2020 - 2021)

Historic Liabilities and Shareholders Equity for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to $400.4 million.

  • Design Therapeutics' Liabilities and Shareholders Equity changed N/A to $400.4 million in Q3 2021 from the same period last year, while for Dec 2021 it was $1.2 billion, marking a year-over-year increase of 323375.23%. This contributed to the annual value of $36.5 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q3 2021, Design Therapeutics' Liabilities and Shareholders Equity is $400.4 million.
  • Design Therapeutics' 5-year Liabilities and Shareholders Equity high stood at $411.9 million for Q1 2021, and its period low was $36.5 million during Q4 2020.